Action Alert: Lock in Remaining IAG Profits
Take 60% Gainer
PLAY: Sell the remainder of your IAM Gold September 5 Calls (IAG IA) at market, good for the day.
Dear Bottarelli Research Member,
Perhaps this goes against the conventional thinking process, but I’d like to lock in the remaining profits on our IAM Gold September 5 Calls (IAG IA). As you know, we entered these calls on February 2nd for $2.55, and they just hit a high today of $4.10, good for a really nice 60.78% gainer.
Now I admit, IAG has everything moving in their direction. In fact, shares could easily break past $10.00 very soon. But my fear is that everyone right now it talking about gold — and I’ve learned that this often times signals a near-term top. Therefore, gold prices could dip back down going forward which means that the ideal time to lock in profits is now! As you can see below, IAG has had an incredible run, and we can always buy back in on any forthcoming price dips. But for today, let’s take the safe route and lock in our gains!

PLAY: Sell the remainder of your IAM Gold September 5 Calls (IAG IA) at market, good for the day.
At the same time, our decision to add to our Teva Pharmaceuticals January 2010 45 Calls (WTX AI) could not have been any better. Despite a horrible market, shares of TEVA have blasted off today, supporting my thesis that biotech and generic drug companies will out-perform the markets here in 2009.

After adding to our calls, we’re now up 20% on this play — and looking to move even higher. Therefore, hold for more gains!
Sincerely,
© 2012 CSR Group, LLC. All rights reserved. Published in USA.
Information, opinion, research, and commentary contained herein is obtained from sources believed to be reliable; their reliability, however, cannot be guaranteed. The maxim of Caveat Emptor applies — let the buyer beware. Bottarelli Research does not provide individual investment advice, act as an investment advisor, or individually advocate the purchase or sale of any security or investment.
Investments recommended in this service should be made only after consulting with your investment advisor, and only after reviewing the prospectus or financial statements of the company. Bottarelli Research reserves the right to use e-mail endorsements and/or profit claims from its subscribers for marketing purposes. All names will be kept anonymous and only subscriber’s initials will be used unless express written permission has been granted to the contrary.
CSR Group, LLC expressly forbids its writers from having a financial interest in any security recommended to readers. Furthermore, all employees and agents of CSR Group, LLC and its affiliate companies must wait 24 hours before following a published recommendation.

